Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cuiyu Guo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Medicinal Chemistry|May 14, 2020
Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studiesQinhuai Lai, Mengdan Wu, Ruixue Wang, et al.
Biochemical Pharmacology|July 11, 2026
Dual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of monocytic acute myeloid leukemiaXiaofeng Chen, Cuiyu Guo, Yongyan Tu, et al.
Journal of Hematology & Oncology|December 29, 2022
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphomaGuangbing Zhang, Cuiyu Guo, Yan Wang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Medicinal Chemistry|May 14, 2020
Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studiesQinhuai Lai, Mengdan Wu, Ruixue Wang, et al.
Biochemical Pharmacology|July 11, 2026
Dual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of monocytic acute myeloid leukemiaXiaofeng Chen, Cuiyu Guo, Yongyan Tu, et al.
Journal of Hematology & Oncology|December 29, 2022
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphomaGuangbing Zhang, Cuiyu Guo, Yan Wang, et al.
Pageof 2